Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
114

Summary

Conditions
  • Advanced Breast Cancer
  • Breast Cancer
  • Fallopian Tube Cancer
  • Metastatic Breast Cancer
  • Neoplasms
  • Ovarian Cancer
  • Peritoneal Cancer
  • Stage IV Breast Cancer
  • Triple -Negative Breast Cancer
Type
Interventional
Phase
Phase 1Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02657889
Collaborators
Merck Sharp & Dohme Corp.
Investigators
Study Director: GSK Clinical Trials GlaxoSmithKline